CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

1148 results.
Study Number Lead Group Study Title CIRB Study Status
UMI23-13-01 CP-CTNet_LAO-University of Michigan An Early Phase 1 Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy Cancer Prevention and Control CIRB Available to Open
UMI21-05-01 CP-CTNet_LAO-University of Michigan Obeticholic Acid for Prevention in Barrett’s Esophagus Cancer Prevention and Control CIRB Available to Open
10231 NCORP-National Institutes of Health NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study Adult CIRB - Late Phase Emphasis Available to Open
10272 NCORP-National Institutes of Health A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PSMA)-Based PET Imaging of High Risk Prostate Cancer Adult CIRB - Late Phase Emphasis Available to Open
CCTG-PR24 CCTG Androgen Suppression Combined with Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost in Patients with Unfavourable Risk Localized Prostate Cancer (ASCENDE SBRT) Adult CIRB - Late Phase Emphasis Available to Open
CCTG-NE1 CCTG NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus in Metastatic/Unresectable Midgut NET Adult CIRB - Late Phase Emphasis Available to Open
CCTG-CO32 CCTG The NEO-RT Trial: A Phase 3 Randomized Trial of Neoadjuvant Chemotherapy, Excision and Observation versus ChemoRadioTherapy for Early Rectal Cancer Adult CIRB - Late Phase Emphasis Available to Open
MM1YA-CTG01 CCTG A Measurable Residual Disease (MRD) Focused, Phase II Study of Venetoclax plus Chemotherapy for Newly Diagnosed Younger Patients with Intermediate Risk Acute Myeloid Leukemia: A Tier 1 MyeloMATCH Clinical Trial Adult CIRB - Late Phase Emphasis Available to Open
1148 results.